A detailed history of Oversea Chinese Banking Corp LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Oversea Chinese Banking Corp LTD holds 1,319 shares of REGN stock, worth $973,422. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,319
Previous 341 286.8%
Holding current value
$973,422
Previous $358,000 287.15%
% of portfolio
0.04%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$1024.09 - $1201.76 $1 Million - $1.18 Million
978 Added 286.8%
1,319 $1.39 Million
Q2 2024

Aug 05, 2024

BUY
$883.2 - $1071.19 $301,171 - $365,275
341 New
341 $358,000
Q4 2022

Sep 15, 2023

BUY
$705.89 - $766.39 $418,592 - $454,469
593 New
593 $427,000
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $418,592 - $454,469
593 New
593 $0

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.